Caribou Biosciences Inc. (NASDAQ: CRBU): Oppenheimer reiterated its Outperform rating with a $36 target price. The consensus target is $29.43. The shares were crushed Monday, down a sharp 26%, despite posting solid clinical data last Friday.
Coinbase Global Inc. (NASDAQ: COIN): J.P. Morgan downgraded the cryptocurrency brokerage to Neutral from Overweight and slashed the $171 price target to $68. The consensus target is $149.17. The stock closed almost 12% lower on Monday at $52.01.
Covetrus Inc. (NASDAQ: CVET): Stifel cut its Buy rating to Hold with a $22 target price. The consensus target is $21.33. The stock closed on Monday at $20.67.
Dell Technologies Inc. (NYSE: DELL): The Zacks Bull of the Day stock has seen Wall Street positively revising quarterly estimates, says the analyst. Shares last closed at $47.25, and the consensus target price is $60.06.
Editas Medicine Inc. (NASDAQ: EDIT): Goldman Sachs maintained a Sell rating and has an $8 target price. The consensus target is $32.23 for now. Monday’s $10.00 close was down over 10% on the day.
Fidelity National Information Services Inc (NYSE: FIS): Evercore ISI’s upgrade to Outperform from In Line included a price target boost to $135 from $115. The consensus target is $132.88. The final trade for Monday was reported at $94.96.
Generac Holdings Inc. (NYSE: GNRC): Baird reiterated an Outperform rating with a $298 target price. That compares with a $386.65 consensus target and the final print on Monday at $244.52.
Hannon Armstrong Sustainable Infrastructure Capital Inc. (NYSE: HASI) Oppenheimer maintained an Outperform rating and has a $62 target price. The consensus target is $59.13. The shares ended Monday down almost 9% to $34.88.
Invesco Ltd. (NYSE: IVZ): BMO Capital Markets downgraded shares of the investment giant to Market Perform from Outperform and cut the $25 price target to $20. Monday’s closing trade was reported at $15.93, down close to 8% for the day, after hitting a 52-week low of $15.82 earlier in the day.
Kontoor Brands Inc. (NYSE: KTB): Goldman Sachs downgraded the stock to Neutral from Buy and lowered the price target to $34. The consensus target is $51.57. The shares were last seen Monday at $34.00.
Magellan Midstream Partners L.P. (NYSE: MMP): Goldman Sachs raised its Neutral rating to Buy with a $59 target price. The consensus target is $54.53. The stock closed at $51.61 on Monday.
Marathon Petroleum Corp. (NYSE: MPC): BMO Capital Markets started coverage with an Outperform rating and a $135 target price. The consensus target is $117.08. The stock closed on Monday at $102.17.
Sponsored: Tips for Investing
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.